Key Events This Week
2 Mar: Stock drops 5.78% amid broad market weakness
4 Mar: Further decline of 8.03% on low volume
5 Mar: Sharp rebound with 8.93% gain supported by technical momentum
6 Mar: Downgrade to Sell and mixed technical signals weigh on price, closing near Rs.137.20
Ind-Swift Laboratories Gains 0.18%: 2 Key Factors Driving the Week
2026-03-14 15:03:05
Key Events This Week
09 Mar: Mojo grade upgraded to Hold on improved technicals and financial trends
10 Mar: Bullish momentum confirmed with 3.13% intraday gain closing at Rs.141.50
13 Mar: Sharp decline of 4.02% amid broader market weakness
Week Summary: Stock ends at Rs.137.45, outperforming Sensex by 5.05%

Ind-Swift Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Trends
2026-03-10 08:16:24Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 9 March 2026, is driven by a combination of bullish technical trends, strong quarterly earnings growth, and a more favourable valuation outlook, despite some lingering concerns over long-term fundamentals.
Read full news article
Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades
2026-03-10 08:01:31Ind-Swift Laboratories Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The pharmaceutical and biotechnology company’s shares have surged 3.13% today, closing at ₹141.50, reflecting renewed investor confidence and a positive outlook following recent technical upgrades.
Read full news article
Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-03-06 08:05:32Ind-Swift Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 5 March 2026, reflecting a complex interplay of technical indicators, valuation concerns, financial trends, and quality assessments. Despite recent positive quarterly results and strong stock returns, underlying fundamental weaknesses and mixed technical signals have prompted a cautious stance from analysts.
Read full news article
Ind-Swift Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-03-06 08:00:53Ind-Swift Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. While some indicators signal bullish tendencies, others suggest caution, resulting in a mildly bullish outlook overall. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
03-Apr-2026 | Source : BSEPlease refer attached pdf.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
31-Mar-2026 | Source : BSEIntimation of allotment of 125000 shares pursuant to ESOP 2014
Closure of Trading Window
31-Mar-2026 | Source : BSEIntimation regarding closure of Trading Window w.e.f. 1st April 2026.
Corporate Actions
No Upcoming Board Meetings
Ind-Swift Laboratories Ltd has declared 10% dividend, ex-date: 20 Sep 11
No Splits history available
No Bonus history available
No Rights history available









